• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经退行性疾病中的 microRNAs。

MicroRNAs in neurodegenerative disorders.

机构信息

Center for Neurodegenerative and Neuroimmunologic Diseases, Department of Neurology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ, USA.

出版信息

Cell Cycle. 2010 May;9(9):1717-21. doi: 10.4161/cc.9.9.11296. Epub 2010 May 25.

DOI:10.4161/cc.9.9.11296
PMID:20404550
Abstract

MicroRNAs (miRNAs) are endogenous, small, noncoding RNAs regulating eukaryotic gene expression at the post-transcriptional level. During the last decade, considerable advances have been made in our understanding the biogenesis of miRNAs, the molecular mechanisms by which they regulate gene expression and their functional role in various physiological situations. miRNAs are abundant in the brain where they have crucial roles in development and synaptic plasticity. Accumulating evidence from postmortem brain analyses and animal model studies has begun to suggest that miRNA dysfunction contributes to neurodegenerative disorders. Here, we discuss several examples of investigations demonstrating the role of miRNAs in neurodegenerative disorders. As the expression of disease-causing genes is regulated by certain miRNA(s), changes in these miRNAs could lead to the accumulation of disease-causing proteins, and subsequently to neuronal dysfunction and death. Detailed understanding of these mechanisms can provide potential new therapeutic approaches to slow down or halt the progression of neurodegenerative diseases.

摘要

MicroRNAs (miRNAs) 是内源性的、小的、非编码 RNA,在转录后水平调节真核生物基因表达。在过去的十年中,我们在 miRNA 的生物发生、它们调节基因表达的分子机制以及它们在各种生理情况下的功能作用方面取得了相当大的进展。miRNAs 在大脑中含量丰富,在大脑发育和突触可塑性中发挥着关键作用。来自脑尸检分析和动物模型研究的越来越多的证据开始表明,miRNA 功能障碍导致神经退行性疾病。在这里,我们讨论了几个证明 miRNA 在神经退行性疾病中的作用的研究示例。由于致病基因的表达受某些 miRNA 的调节,这些 miRNA 的变化可能导致致病蛋白的积累,进而导致神经元功能障碍和死亡。对这些机制的详细了解可以为减缓或阻止神经退行性疾病的进展提供潜在的新治疗方法。

相似文献

1
MicroRNAs in neurodegenerative disorders.神经退行性疾病中的 microRNAs。
Cell Cycle. 2010 May;9(9):1717-21. doi: 10.4161/cc.9.9.11296. Epub 2010 May 25.
2
MicroRNAs in neurodegenerative diseases and their therapeutic potential.神经退行性疾病中的 microRNAs 及其治疗潜力。
Pharmacol Ther. 2012 Feb;133(2):142-50. doi: 10.1016/j.pharmthera.2011.10.002. Epub 2011 Oct 8.
3
Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.靶向微小RNA用于神经退行性疾病的预防和治疗。
Drug Dev Res. 2015 Nov;76(7):397-418. doi: 10.1002/ddr.21277. Epub 2015 Sep 11.
4
MicroRNAs in glaucoma and neurodegenerative diseases.青光眼和神经退行性疾病中的微小RNA
J Hum Genet. 2017 Jan;62(1):105-112. doi: 10.1038/jhg.2016.91. Epub 2016 Jul 14.
5
MicroRNAs: novel therapeutic targets in neurodegenerative diseases.微小 RNA:神经退行性疾病的新治疗靶点。
Drug Discov Today. 2009 Dec;14(23-24):1123-9. doi: 10.1016/j.drudis.2009.09.009. Epub 2009 Oct 12.
6
MicroRNAs and their therapeutic potential for human diseases: aberrant microRNA expression in Alzheimer's disease brains.微小 RNA 及其在人类疾病治疗中的潜力:阿尔茨海默病大脑中的异常微小 RNA 表达。
J Pharmacol Sci. 2010;114(3):269-75. doi: 10.1254/jphs.10r11fm. Epub 2010 Oct 9.
7
Defining larger roles for "tiny" RNA molecules: role of miRNAs in neurodegeneration research.定义“微小”RNA 分子的更大作用:miRNA 在神经退行性变研究中的作用。
J Neuroimmune Pharmacol. 2010 Mar;5(1):63-9. doi: 10.1007/s11481-009-9172-4. Epub 2009 Sep 16.
8
microRNA dysregulation in neurodegenerative diseases: A systematic review.microRNA 失调与神经退行性疾病:系统综述。
Prog Neurobiol. 2019 Nov;182:101664. doi: 10.1016/j.pneurobio.2019.101664. Epub 2019 Jul 26.
9
Searching for MIND: microRNAs in neurodegenerative diseases.探寻MIND:神经退行性疾病中的微小RNA
J Biomed Biotechnol. 2009;2009:871313. doi: 10.1155/2009/871313. Epub 2009 Aug 23.
10
Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs.小鼠胚胎干细胞表达内源性短发夹RNA、小干扰RNA以及其他不依赖微处理器、依赖Dicer的小RNA。
Genes Dev. 2008 Oct 15;22(20):2773-85. doi: 10.1101/gad.1705308.

引用本文的文献

1
The Role of microRNAs Related to Apoptosis for -Methyl-d-Aspartic Acid-Induced Neuronal Cell Death in the Murine Retina.凋亡相关微小 RNA 在 -甲基-d-天冬氨酸诱导的小鼠视网膜神经元细胞死亡中的作用。
Int J Mol Sci. 2024 Jan 16;25(2):1106. doi: 10.3390/ijms25021106.
2
State of the Art of microRNAs Signatures as Biomarkers and Therapeutic Targets in Parkinson's and Alzheimer's Diseases: A Systematic Review and Meta-Analysis.作为帕金森病和阿尔茨海默病生物标志物及治疗靶点的微小RNA特征研究现状:一项系统综述与荟萃分析
Biomedicines. 2023 Apr 7;11(4):1113. doi: 10.3390/biomedicines11041113.
3
Therapeutics in the Pipeline Targeting -Synuclein for Parkinson's Disease.
针对帕金森病的α-突触核蛋白的在研治疗方法
Pharmacol Rev. 2022 Jan;74(1):207-237. doi: 10.1124/pharmrev.120.000133.
4
MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse Brain.MicroRNA-7 对α-突触核蛋白原纤维诱导的小鼠脑神经元变性具有保护作用。
Neurotherapeutics. 2021 Oct;18(4):2529-2540. doi: 10.1007/s13311-021-01130-6. Epub 2021 Oct 25.
5
Differentiation Induction and Proliferation Inhibition by A Cell-Free Approach for Delivery of Exogenous miRNAs to Neuroblastoma Cells Using Mesenchymal Stem Cells.利用间充质干细胞通过无细胞方法向神经母细胞瘤细胞递送外源性微小RNA实现分化诱导和增殖抑制
Cell J. 2021 Jan;22(4):556-564. doi: 10.22074/cellj.2021.6928. Epub 2020 Apr 27.
6
Nucleic Acid-Based Therapeutics for Parkinson's Disease.基于核酸的帕金森病治疗方法。
Neurotherapeutics. 2019 Apr;16(2):287-298. doi: 10.1007/s13311-019-00714-7.
7
The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress.帕金森病基因产物 DJ-1 调节 miR-221 以促进神经元在氧化应激下的存活。
Redox Biol. 2018 Oct;19:62-73. doi: 10.1016/j.redox.2018.07.021. Epub 2018 Aug 3.
8
Paraquat and MPTP induce neurodegeneration and alteration in the expression profile of microRNAs: the role of transcription factor Nrf2.百草枯和1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导神经退行性变及微小RNA表达谱改变:转录因子Nrf2的作用
NPJ Parkinsons Dis. 2017 Oct 20;3:31. doi: 10.1038/s41531-017-0033-1. eCollection 2017.
9
Low-variance RNAs identify Parkinson's disease molecular signature in blood.低变异RNA可识别血液中帕金森病的分子特征。
Mov Disord. 2015 May;30(6):813-21. doi: 10.1002/mds.26205. Epub 2015 Mar 18.
10
Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.在阿尔茨海默病小鼠模型中,通过抑制2-花生四烯酸甘油(2-AG)代谢实现的突触和认知改善是通过上调微小RNA-188-3p来实现的。
J Neurosci. 2014 Nov 5;34(45):14919-33. doi: 10.1523/JNEUROSCI.1165-14.2014.